von Heesen A, Takacs Z, Gabriel L, Hamza A, Linxweiler M, von Heesen M, Meyberg-Solomayer G, Solomayer E-F, Juhasz-Böss I
Department of Obstetrics and Gynecology, University of Saarland, Kirrbergerstr. 100, 66424, Homburg/Saar, Germany.
Department of Otorhinolaryngology, Head and Neck Surgery, University of Saarland, Kirrbergerstr. 100, 66424, Homburg/Saar, Germany.
Arch Gynecol Obstet. 2016 Oct;294(4):847-54. doi: 10.1007/s00404-016-4102-1. Epub 2016 May 13.
The laparoscopic surgery of uterine cancer is an oncological safe treatment option in early stage cancer. However, there are no data about whether laparoscopy can lead to intraperitoneal tumor cell dissemination. We aimed in our study to detect a possible cytological conversion during laparoscopic procedures.
In this prospective study, we included all patients receiving laparoscopic treatment at the early stage endometrial and cervical cancer in the Department of Obstetrics and Gynecology at the University of the Saarland and obtained peritoneal wash for cytological examination at the beginning and at the end of laparoscopic surgery. All patients received stage-adjusted operative and adjuvant therapy.
We enrolled 43 patients [endometrial cancer (n = 24) and cervical cancer (n = 19)]. At the beginning of the operation, one patient with endometrial cancer and one patient with cervical cancer showed a positive cytology. One tumor cell conversion from negative to positive cytology during surgery was detected in a patient suffering from endometrial cancer stage FIGO Ia. The median duration of surgery was 191.8 ± 79.3 min. The average time of follow-up was 16.5 ± 10.3 month. At the end of data evaluation at December 2014, two patients (8.6 %) are suffering from recurrent disease, two patients died, none of these patients had a positive cytology. All patients with positive cytology are free of cancer.
During laparoscopic surgery of early stage endometrial and cervical cancer, only one conversion of cytology was detected, which proves that laparoscopy does not appear to increase the intraoperative tumor cell dissemination or rate of positive cytological results.
子宫癌的腹腔镜手术是早期癌症的一种肿瘤学安全治疗选择。然而,关于腹腔镜手术是否会导致腹腔内肿瘤细胞播散尚无相关数据。我们的研究旨在检测腹腔镜手术过程中可能出现的细胞学转变。
在这项前瞻性研究中,我们纳入了萨尔兰大学妇产科接受腹腔镜治疗的所有早期子宫内膜癌和宫颈癌患者,并在腹腔镜手术开始时和结束时获取腹腔冲洗液进行细胞学检查。所有患者均接受了根据分期调整的手术和辅助治疗。
我们纳入了43例患者[子宫内膜癌(n = 24)和宫颈癌(n = 19)]。手术开始时,1例子宫内膜癌患者和1例宫颈癌患者细胞学检查呈阳性。在1例FIGO Ia期子宫内膜癌患者的手术过程中检测到1例肿瘤细胞从细胞学阴性转变为阳性。手术中位时长为191.8 ± 79.3分钟。平均随访时间为16.5 ± 10.3个月。在2014年12月数据评估结束时,2例患者(8.6%)患有复发性疾病,2例患者死亡,这些患者中无一例细胞学检查呈阳性。所有细胞学检查呈阳性的患者均无癌症。
在早期子宫内膜癌和宫颈癌的腹腔镜手术过程中,仅检测到1例细胞学转变,这证明腹腔镜手术似乎不会增加术中肿瘤细胞播散或细胞学阳性结果的发生率。